Co-Authors
This is a "connection" page, showing publications co-authored by Antonio Bellasi and Claudio Ronco.
Connection Strength
1.980
-
Cardiorenal Syndrome in Acute Kidney Injury. Semin Nephrol. 2019 01; 39(1):31-40.
Score: 0.201
-
Cardiac valve calcification and use of anticoagulants: Preliminary observation of a potentially modifiable risk factor. Int J Cardiol. 2019 Mar 01; 278:243-249.
Score: 0.199
-
Search for a reliable biomarker of acute kidney injury: to the heart of the problem. Ann Transl Med. 2018 Nov; 6(Suppl 1):S5.
Score: 0.198
-
Chronic Hyperkalemia in Cardiorenal Patients: Risk Factors, Diagnosis, and New Treatment Options. Cardiorenal Med. 2019; 9(1):8-21.
Score: 0.198
-
Cardiorenal Syndrome: An Overview. Adv Chronic Kidney Dis. 2018 09; 25(5):382-390.
Score: 0.196
-
Safety and effectiveness of rivaroxaban and warfarin in moderate-to-advanced CKD: real world data. J Nephrol. 2018 Oct; 31(5):751-756.
Score: 0.193
-
[Non vitamin-K dependent oral anticoagulants (NOACs) in chronic kidney disease patients with non-valvular atrial fibrillation]. G Ital Nefrol. 2017 Apr; 34(2):58-73.
Score: 0.178
-
[Hepato-renal syndrome]. G Ital Nefrol. 2017 Mar; 34(Suppl 69):178-187.
Score: 0.177
-
[NOACs and Chronic kidney disease]. G Ital Nefrol. 2017 Mar; 34(Suppl 69):188-204.
Score: 0.177
-
[Newer anti - diabetic therapies and chronic kidney disease]. G Ital Nefrol. 2017 Jan-Feb; 34(1).
Score: 0.175
-
[Neprilysin inhibition and chronic kidney disease]. G Ital Nefrol. 2017 Sep 28; 34(5):102-112.
Score: 0.046
-
The treatment of type 2 diabetes mellitus in patients with chronic kidney disease: What to expect from new oral hypoglycemic agents. Diabetes Metab Syndr. 2017 Nov; 11 Suppl 1:S295-S305.
Score: 0.044